Castleark Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-177,874
Closed -$4.93M 289
2024
Q3
$4.93M Sell
177,874
-50,290
-22% -$1.26M 0.2% 125
2024
Q2
$5.44M Sell
228,164
-2,280
-1% -$53.5K 0.22% 106
2024
Q1
$4.06M Sell
230,444
-19,616
-8% -$289K 0.17% 137
2023
Q4
$3.95M Buy
+250,060
New +$2.58M 0.17% 140

Other funds holding ASPN

Castleark Management's ASPN Position: Q4 2024 in Review

Castleark Management sold out of Aspen Aerogels (ASPN) in Q4 2024, closing a stake of 177,874 shares — an estimated $4.93M sold.

Castleark Management first reported a position in ASPN in Q4 2023 and held it in 4 quarters. The position peaked at $5.44M in Q2 2024. 231 funds tracked by Wall St. Rank hold ASPN as of Q4 2024.

  • Castleark Management reported no remaining Aspen Aerogels position as of Q4 2024 after selling out during the quarter.
  • Castleark Management sold 177,874 Aspen Aerogels shares in Q4 2024, an estimated $4.93M.
  • Castleark Management first reported a position in Aspen Aerogels in Q4 2023 and held it in 4 quarters.
  • Castleark Management's Aspen Aerogels position peaked at $5.44M in Q2 2024.
  • 231 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2024.

Based on Castleark Management's 13F filing for Q4 2024, filed 18 Feb 2025.